ALBANY, N.Y.--(BUSINESS WIRE)--
AngioDynamics (NASDAQ: ANGO), a leading provider of innovative medical
devices for the minimally-invasive treatment of cancer and peripheral
vascular disease, today announced that it will present at the Stephens
Inc.Fall Investment Conference at 1:30 p.m. ET on Wednesday, November
17, 2010, at The New York Palace Hotel. Joseph Gersuk, Executive Vice
President and Chief Financial Officer of AngioDynamics, will review the
Company's business strategy and recent corporate developments.
Attendance at the conference is by invitation only. Individuals can view
an archived webcast and slide presentation on the Internet by visiting
the investor relations portion of the Company's Web site at: http://investors.angiodynamics.com.
The archived presentation will be available for 90 days.
AngioDynamics, Inc. is a leading provider of innovative medical devices
used by interventional radiologists, surgeons and other physicians for
the minimally-invasive treatment of cancer and peripheral vascular
disease. AngioDynamics' diverse product lines include market-leading
radiofrequency and irreversible electroporation ablation systems,
vascular access products, angiographic products and accessories,
dialysis products, angioplasty products, drainage products, thrombolytic
products, embolization products and venous products. More information is
available at www.angiodynamics.com.
D. Joseph Gersuk, CFO,
800-772-6446 ext. 1608
Doug Sherk, 415-896-6820 (Investor Relations)
Gin, 415-896-6820 (Investor Relations)
Gale, 646-201-5431 (Media)
Source: AngioDynamics, Inc.
News Provided by Acquire Media